What is the recommended treatment for pneumonitis in children?

Treatment for Pediatric Pneumonitis (Community-Acquired Pneumonia)

High-dose oral amoxicillin at 90 mg/kg/day divided into 2 doses is the definitive first-line treatment for children over 3 months of age with community-acquired pneumonia, providing optimal coverage against Streptococcus pneumoniae, the most common bacterial pathogen. 1, 2

Outpatient Management Algorithm

Children Under 5 Years

• Prescribe amoxicillin 90 mg/kg/day divided into 2 doses (maximum 4 g/day) for 7 days as first-line therapy for presumed bacterial pneumonia 2, 3
• The high dose of 90 mg/kg/day is essential to overcome penicillin-resistant Streptococcus pneumoniae with MICs up to 2–4 mg/L 2
• Underdosing with 40-45 mg/kg/day is a dangerous and common error that leads to treatment failure 2
• Macrolides are not indicated as first-line therapy in this age group because atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae) are uncommon under age 5 2

Children 5 Years and Older

• Start with amoxicillin 90 mg/kg/day divided into 2 doses (maximum 4 g/day) 2, 3
• Add azithromycin (10 mg/kg on day 1, then 5 mg/kg/day on days 2-5) if atypical pathogens cannot be clinically excluded based on presentation 1, 2, 3
• Clinical features suggesting atypical pneumonia include gradual onset, prominent headache, malaise, and interstitial infiltrates on imaging 2

Alternative Oral Regimens

• For incompletely immunized children or suspected β-lactamase-producing organisms: use amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day divided into 2 doses) 2, 4
• For non-anaphylactic penicillin allergy: use cefpodoxime, cefuroxime, or cefprozil under medical supervision (cross-reactivity risk 1-3%) 2, 3
• For severe penicillin allergy (anaphylaxis): use levofloxacin 16-20 mg/kg/day divided twice daily for children 6 months to 5 years, or 8-10 mg/kg once daily for children 5-16 years (maximum 750 mg/day) 1, 2

Inpatient Management Algorithm

Fully Immunized, Low-Risk Children

• Ampicillin 150-200 mg/kg/day IV every 6 hours or penicillin G 200,000-250,000 U/kg/day IV every 4-6 hours as preferred first-line therapy in areas with minimal penicillin resistance 1, 2
• Alternative: ceftriaxone 50-100 mg/kg/day IV every 12-24 hours for convenient once-daily dosing 1, 2

Not Fully Immunized or High-Risk Children

• Ceftriaxone 50-100 mg/kg/day IV every 12-24 hours or cefotaxime 150 mg/kg/day IV every 8 hours as empiric therapy 1, 2
• These third-generation cephalosporins provide reliable coverage of penicillin-resistant S. pneumoniae (MIC ≥ 4 µg/mL), β-lactamase-producing H. influenzae, and Klebsiella pneumoniae 2

When to Add MRSA Coverage

• Add vancomycin 40-60 mg/kg/day IV every 6-8 hours or clindamycin 40 mg/kg/day IV every 6-8 hours to β-lactam therapy when any of the following are present: 1, 2
  • Necrotizing infiltrates on imaging 2
  • Pleural effusion or empyema 1, 2
  • Severe pneumonia following recent influenza infection 2
  • Failure of adequate β-lactam therapy with clinical deterioration 2

Atypical Pathogen Coverage (Hospitalized)

• Add azithromycin IV 10 mg/kg on days 1 and 2, then transition to oral therapy when M. pneumoniae or C. pneumoniae are significant considerations 1, 2

Treatment Duration and Monitoring

• Standard duration is 7 days for uncomplicated pneumonia 2, 3, 4
• Children should demonstrate clinical improvement within 48-72 hours, including fever resolution, reduced respiratory rate, decreased work of breathing, and improved oral intake 1, 2, 3
• If no improvement occurs within 48-72 hours, reassess for: 1, 2, 3
  • Inadequate antibiotic dosing or inappropriate drug selection
  • Atypical pathogens requiring macrolide addition
  • Complications (parapneumonic effusion, empyema, necrotizing pneumonia)
  • Resistant organisms (especially MRSA)
  • Alternative diagnoses

Criteria for Hospitalization

Admit to hospital if any of the following are present: 4

• Oxygen saturation < 92% on room air 4
• Moderate to severe respiratory distress with increased work of breathing (retractions, nasal flaring, grunting) 4
• Inability to tolerate oral intake or medications 4
• Suspected community-acquired MRSA infection 4
• Concerns about safe home observation or inability to secure follow-up 4

Switching from IV to Oral Therapy

• Switch to oral antibiotics when: 4
  • Child is afebrile for 24 hours
  • Respiratory rate and work of breathing have improved
  • Child is tolerating oral intake without vomiting
  • Typically occurs within 48-72 hours of IV therapy 4

Critical Pitfalls to Avoid

• Do not use macrolides as monotherapy in children < 5 years due to inadequate S. pneumoniae coverage 2, 3
• Do not underdose amoxicillin at 40-45 mg/kg/day instead of the required 90 mg/kg/day 2
• Do not fail to consider MRSA in children with severe pneumonia, necrotizing infiltrates, or empyema 2
• Do not use cefixime or other second-generation cephalosporins as first-line therapy for pediatric pneumonia 2
• Do not delay treatment while attempting to clarify allergy history—start appropriate therapy immediately 2